Hua Ke is the founder of Angitia Biopharmaceuticals. Angitia Biopharmaceuticals has raised $406M in total funding. Latest round: Series D.
Hua Zhu (David) Ke is the founder and CEO of Angitia Biopharmaceuticals, a clinical-stage biotechnology company co-founded in 2018 with Muyu Li. He leads the company's dual operations in California and China, overseeing a pipeline of bispecific antibodies targeting musculoskeletal diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library